Extrawell Pharmaceutical Holdings Ltd

00858

Company Profile

  • Business description

    Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing; Trading and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. The gene development segment is engaged in the commercial exploitation and development of genome-related technology. Geographically, it derives a majority of its revenue from China.

  • Contact

    979 King’s Road
    Suites 2206-08, 22nd Floor
    Devon House, Taikoo Place
    Quarry Bay
    Hong Kong
    HKG

    T: +852 28561918

    http://www.extrawell.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2025

    Employees

    162

Stocks News & Analysis

stocks

2 undervalued ASX shares report

These two ASX shares are trading at a discount to our fair value. 
stocks

Turmoil at WiseTech

Board members step down over differences on the role of former CEO Richard White.
video

What does the RBA rate cut mean for investors?

Morningstar's Chief Investment Officer for Asia-Pacific and Director of Personal Finance share their thoughts on the recent RBA rate cut.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,494.5065.60-0.77%
CAC 408,090.9963.52-0.78%
DAX 4022,425.93138.370.62%
Dow JONES (US)43,461.2133.190.08%
FTSE 1008,658.980.39-0.00%
HKSE22,998.69342.92-1.47%
NASDAQ19,286.93237.08-1.21%
Nikkei 22538,345.99430.95-1.11%
NZX 50 Index12,355.74175.98-1.40%
S&P 5005,983.2529.88-0.50%
S&P/ASX 2008,247.0061.20-0.74%
SSE Composite Index3,359.2713.76-0.41%

Market Movers